JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 83 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,406,000 | +8.7% | 168,424 | -3.3% | 0.03% | +16.0% |
Q3 2021 | $1,294,000 | -46.8% | 174,175 | -51.3% | 0.02% | -44.4% |
Q2 2021 | $2,433,000 | -30.1% | 357,817 | +5.6% | 0.04% | -39.2% |
Q1 2021 | $3,481,000 | +24.3% | 338,969 | -15.3% | 0.07% | +17.5% |
Q4 2020 | $2,800,000 | -27.2% | 400,013 | -15.2% | 0.06% | -51.9% |
Q3 2020 | $3,848,000 | +8.1% | 471,622 | -8.6% | 0.13% | +1.6% |
Q2 2020 | $3,559,000 | +183.6% | 515,748 | +95.3% | 0.13% | +89.7% |
Q1 2020 | $1,255,000 | +17.5% | 264,139 | +116.0% | 0.07% | +38.8% |
Q4 2019 | $1,068,000 | +161.1% | 122,282 | -0.5% | 0.05% | +113.0% |
Q3 2019 | $409,000 | -28.9% | 122,912 | +5.9% | 0.02% | -17.9% |
Q2 2019 | $575,000 | -26.1% | 116,080 | -7.5% | 0.03% | -33.3% |
Q1 2019 | $778,000 | +75.6% | 125,533 | -4.5% | 0.04% | +35.5% |
Q4 2018 | $443,000 | -49.6% | 131,393 | -2.9% | 0.03% | -35.4% |
Q3 2018 | $879,000 | -12.8% | 135,280 | +2.8% | 0.05% | -21.3% |
Q2 2018 | $1,008,000 | -62.6% | 131,592 | +9.1% | 0.06% | -68.7% |
Q1 2018 | $2,695,000 | +79.1% | 120,585 | +2.1% | 0.20% | +65.3% |
Q4 2017 | $1,505,000 | – | 118,060 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |